Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Esketamine on Postoperative Cognitive Function in Elderly Patients Undergoing Oral and Maxillofacial Surgery
NCT07665099Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in perioperative neurocognitive disorders (PND) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Montreal Cognitive Assessment at 1 day. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
perioperative neurocognitive disorders (PND)
Beyond the preview
Go deeper on NCT07665099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07665099.